A Non-inferiority Phase 2 Study to Evaluate the Safety and Efficacy of PEG-rhGH in the Treatment of Adult Growth Hormone Deficiency (AGHD)
Latest Information Update: 07 Sep 2023
Price :
$35 *
At a glance
- Drugs Somatropin (Primary)
- Indications Somatotropin deficiency
- Focus Therapeutic Use
- Sponsors GeneScience Pharmaceuticals
- 11 Apr 2017 New trial record